Koninklijke Philips NV (PHG)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- Symbol
- PHG
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- 52 week range
- 23.85 - 33.44
Valuation
- Share price
- $24.45 (close of 2026-09-23)
- P/E (TTM)
- 23.26x
- Price to book
- 1.92x
- Price to free cash flow
- 23.31x
Price performance
| Period | Change |
|---|---|
| 1 day | -1.81% |
| 5 days | -1.81% |
| 1 month | -10.83% |
| 3 months | -8.12% |
| 6 months | -8.80% |
| Year to date | -9.71% |
| 1 year | -12.05% |
| 3 years | +18.75% |
| 5 years | -47.76% |
| 10 years | -17.84% |
| All time | +1047.89% |
Profitability and growth
- Return on equity
- 8.14%
- Return on invested capital
- 7.13%
- Return on assets
- 3.32%
- Return on capital employed
- 7.33%
- Gross margin
- 45.18%
- Net margin
- 5.02%
- EBITDA margin
- 14.29%
- Revenue growth
- -1.04%
- Net income growth
- 227.49%
- Free cash flow growth
- -27.88%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 4.29%
- Current ratio
- 1.32x
- Net debt to EBITDA
- 1.93x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Shares outstanding
- 948.24M
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 45.18% | 5.02% | 8.14% | 7.13% |
| 2024-12-31 | 43.13% | -3.90% | -5.83% | 1.54% |
| 2023-12-31 | 40.99% | -2.56% | -3.86% | -0.33% |
| 2022-12-31 | 40.35% | -9.02% | -12.11% | -7.28% |
| 2021-12-31 | 41.78% | 19.35% | 22.93% | 2.89% |
| 2020-12-31 | 45.17% | 6.86% | 9.97% | 6.77% |
| 2019-12-31 | 46.07% | 6.81% | 9.24% | 6.69% |
| 2018-12-31 | 47.20% | 6.02% | 9.02% | 9.43% |
| 2017-12-31 | 46.01% | 9.32% | 13.82% | 7.97% |
| 2016-12-31 | 45.57% | 8.31% | 10.76% | 7.64% |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-03
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-07-28 | Jun/2026 | - |
| 2026-05-06 | - | - |
| 2025-11-04 | - | - |
| 2025-07-29 | - | - |
| 2025-05-06 | - | - |
| 2025-02-19 | - | - |
| 2024-10-28 | - | - |
| 2024-07-29 | - | - |
Filings and sources
- Company website
- philips.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Abbott Laboratories (ABT) · Medtronic plc (MDT) · Stryker Corp (SYK) · Boston Scientific Corp (BSX) · Edwards Lifesciences Corp (EW) · Dexcom Inc (DXCM) · STERIS plc (STE) · Zimmer Biomet Holdings, Inc. (ZBH)
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades